Healthcare & Life Sciences

Rezo Therapeutics

series-a
series-a
Stage
1
Investors

About

Rezo Therapeutics develops antibody therapies using computational modeling to design treatments that modulate protein-protein interactions in diseases.

Explore Rezo Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.